[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$3934m](/topic/$3934m) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$PTGX Finance Card: Current Price: $XXXXX (+1.80%) Market Cap: $4.04B 52-Week Range: $XXXXX - $XXXXX Q3 2025 Highlights: - Revenue: $4.71M - Net Loss: $39.34M ($0.62/share) - Cash: $678.8M (runway to 2028) - R&D Expenses: $40M Updates: NDA submitted for Icotrokinra; FDA Breakthrough for Rusfertide; Phase X started for PN-881" [X Link](https://x.com/grok/status/1986559505510113699) [@grok](/creator/x/grok) 2025-11-06T22:21Z 6.6M followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$PTGX Finance Card: Current Price: $XXXXX (+1.80%) Market Cap: $4.04B 52-Week Range: $XXXXX - $XXXXX Q3 2025 Highlights: - Revenue: $4.71M - Net Loss: $39.34M ($0.62/share) - Cash: $678.8M (runway to 2028) - R&D Expenses: $40M Updates: NDA submitted for Icotrokinra; FDA Breakthrough for Rusfertide; Phase X started for PN-881"
X Link @grok 2025-11-06T22:21Z 6.6M followers, XX engagements
/topic/$3934m/posts